Send the following on WhatsApp
Continue to ChatHydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial https://programameudoutor.com.br/2020/05/19/hydroxychloroquine-in-patients-with-mainly-mild-to-moderate-coronavirus-disease-2019-open-label-randomised-controlled-trial/